Navigation Links
Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
Date:2/5/2008

06. Total operating expenses for the fourth quarter of 2007 were $10.4 million, compared to $12.0 million for the same period in 2006.

Net interest and other income was $935,000 for the fourth quarter of 2007, compared to $858,000 for the same period in 2006, primarily due to higher average cash and investment balances.

Full Year Results

For the year ended December 31, 2007, the consolidated net loss was $21.5 million, or $0.58 per share, compared to a net loss of $17.9 million, or $0.55 per share, for the year ended December 31, 2006. Revenues were $9.1 million for 2007, compared to $7.9 million in 2006. Total operating expenses were $33.9 million in 2007 and $28.6 million in 2006. Operating expenses in 2006 included the acquisition of the Edwards Lifesciences' ZFP Therapeutic angiogenesis program, a one-time cost for Sangamo of $5.8 million. The increase in operating expenses for 2007 was primarily associated with Sangamo's clinical development program in diabetic neuropathy and pre-IND programs to develop ZFP Therapeutics for the treatment of HIV/AIDS and glioblastoma, as well as increased R & D personnel costs and lab supply expenses.

2007 Highlights

-- Presentation of first clinical data from Phase 1b study of SB-509 in

subjects with diabetic neuropathy (DN). Data from the Phase 1b

clinical trial were presented at the American Diabetes Association

Meeting in June and the Society for Neuroscience Meeting in November.

The data demonstrate statistically significant improvement in

quantitative sensory testing and clinically relevant trends toward

improvement in nerve conduction velocity in subjects with mild to

moderate diabetic neuropathy over a six month period after a single

administration of SB-509. SB-509 is an injectable formulation of

plasmid DNA that encodes a zinc finger DNA-binding protein

transcription factor (ZFP
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
4. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
5. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
6. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
7. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
8. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
9. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... R.I. , May 22, 2015 ... once-daily central nervous system stimulant indicated for the ... to patients beginning Summer 2015. ... XR received approval from the U.S. Food and ... is an extended-release formulation of methylphenidate capsule with ...
(Date:5/22/2015)... May 22, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the ... interim chief executive officer Howie Rosen will ... financial officer Tim Morris will be presenting ... two presentations are as follows: Jefferies 2015 ...
(Date:5/21/2015)... , May 21, 2015  When Ryan ... the side of his neck, he figured ... a couple weeks off from weight lifting. ... away.                               A series ... was referred to Michel Kliot, MD ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... Medical Systems, Inc. (NYSE: VAR ), the world,s ... and radiosurgery, is introducing its new TrueBeam™ medical linear accelerator ... 10th annual meeting of the Asia-Oceania Congress of Medical Physics ... The TrueBeam system, which was designed from the ground up ...
... -- China Sky One Medical, Inc. ("China Sky One ... a leading fully integrated pharmaceutical company producing over-the-counter drugs ... that it held its 2010 Annual Meeting of Stockholders ... PRC.   At the Annual Meeting, the ...
Cached Medicine Technology:Varian Medical Systems Introduces New TrueBeam™ System for Image-Guided Radiotherapy and Radiosurgery to Clinicians in Asia at AOCMP in Taipei, Taiwan 2China Sky One Medical, Inc. Reports Outcome of Annual Meeting of Shareholders 2
(Date:5/25/2015)... 2015 Decora Preset 60 Minute Countdown ... available on ‘The Hardware City.’ The product helps in automatically ... a time and the related electronic device is automatically turned ... of the company said, “We are glad that this amazing ... can buy Countdown Timer Switch in just a few clicks. ...
(Date:5/24/2015)... Metamora, Michigan (PRWEB) May 24, 2015 ... for concerns about hair loss. Although it is unclear ... that there are environmental factors such as metabolism, nutritional ... contribute. Since they offer a comprehensive approach to evaluating ... and post-menopausal woman, they can help patients find a ...
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific consulting firm, ... that may have raised the risk of mesothelioma for ... an article on the research. Click here to ... asbestos levels well above OSHA safety guidelines when they ... “Asbestos compliance sampling data associated with the construction, automotive ...
(Date:5/24/2015)... ProPin is a set of self-animating 3D pin markers ... to pin point locations on a map, to indicate prices or ... users to choose from 30 simplistic presets with geometric design elements ... editors can easily manipulate ProPin presets as a whole. Pixel ... , Using ProPin is easy, simply drag a preset into the ...
(Date:5/24/2015)... Geneva, WI (PRWEB) May 24, 2015 ... Mercy Health System CEO - ... principal and honored at the fourth ... held April 15 at Geneva National ... (by school): ,     -Badger High School, ...
Breaking Medicine News(10 mins):Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2
... Pass Bill Includes New Radio Ads Airing Today ... bill to repeal the broken Medicare physician payment formula that ... dimension to its Medicare campaign today with radio ads airing ... ads, the AMA is activating its nationwide grassroots network of ...
... may realize that they have a significant chance of needing ... care, believe government programs cover more than they actually do, ... potential care. A national survey of 935 people ages 21 ... (November) and John Hancock,s "Know Your Options" campaign, found that ...
... still recommended in the first trimester, researchers say , FRIDAY, ... take folic acid in late pregnancy are at increased risk ... study included more than 500 women whose diet and supplements ... asthma at age 3.5 years and at 5.5 years. Asthma ...
... researchers fear , FRIDAY, Nov. 13 (HealthDay News) -- ... 60s with far more physical disabilities than previous generations, ... system. , That,s the finding of University of California, ... and 1999 National Health and Nutrition Examination Surveys to ...
... cancer cells is that they are similar in many respects ... researchers at Karolinska Institutet have found a new way of ... journal Cell . Molecular signal pathways that stimulate ... those active in tumour growth. This limits the possibility of ...
... ... cooperation with PhRMA, will host a workshop on Dried Blood Spot Sampling in the Pharmaceutical ... , ... 13, 2009 -- The Drug Information Association (DIA) , in cooperation with PhRMA, will ...
Cached Medicine News:Health News:AMA Calls on Congress to Pass H.R. 3961, Access to Care for Seniors and Military Families at Stake 2Health News:LTC Awareness Month Finds Americans Still in Dark about Long-Term Care 2Health News:LTC Awareness Month Finds Americans Still in Dark about Long-Term Care 3Health News:LTC Awareness Month Finds Americans Still in Dark about Long-Term Care 4Health News:LTC Awareness Month Finds Americans Still in Dark about Long-Term Care 5Health News:LTC Awareness Month Finds Americans Still in Dark about Long-Term Care 6Health News:Folic Acid Late in Pregnancy Tied to Asthma in Kids 2Health News:Baby Boomers May Prove More Disabled Than Their Elders 2Health News:Paradoxical protein might prevent cancer 2Health News:,DIA/PhRMA Workshop to Explore Dried Blood Spot Sampling Implementation and Advances, 2Health News:,DIA/PhRMA Workshop to Explore Dried Blood Spot Sampling Implementation and Advances, 3
Angled insertion forcep used for the Hydroview lens. Manufactured in titanium....
Titanium. Curved 18 mm shafts with 1.5 wide grasping tip. Flat, serrated cross action handle with dull finish....
30 degree angled tip with 45 mm tip opening. Made with lock. Manufactured in titanium....
Straight 25 gauge shaft with angled tip and sliding inner shaft. Shaft holds the proximal loop against the angled tip while handle in the normal state. Squeeze type handle with dull finish....
Medicine Products: